ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 229

$864K Total Retail Price of All Prescriptions

Rank: 7 out of 229

462 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,343 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 504 407 1 1
LOVASTATIN 405 290 2 11
SERTRALINE HCL 321 213 3 22
FUROSEMIDE 311 240 4 8
OMEPRAZOLE 302 219 5 4
CARVEDILOL 274 196 6 31
LISINOPRIL 256 199 7 2
AMLODIPINE BESYLATE 237 201 8 5
HYDROCODONE-ACETAMINOPHEN 225 148 S3 9 7
GABAPENTIN 213 154 10 10
NAMENDA 180 159 11 39
METFORMIN HCL 176 115 12 6
ZOLPIDEM TARTRATE 161 117 13 20
ENALAPRIL MALEATE 160 135 14 54
OXYCODONE-ACETAMINOPHEN 148 63 S2 15 43
AZITHROMYCIN 133 98 16 53
DONEPEZIL HCL 133 123 16 29
METOPROLOL TARTRATE 133 123 16 13
TRAMADOL HCL 120 76 19 26
ATORVASTATIN CALCIUM 119 109 20 15
AMLODIPINE BESYLATE-BENAZEPRIL 105 88 21 120
POTASSIUM CHLORIDE 97 81 22 18
GEMFIBROZIL 95 82 23 62
PAROXETINE HCL 90 76 24 49
FENTANYL 89 26 S2 25 108
WARFARIN SODIUM 82 69 26 17
DILTIAZEM 24HR CD 82 60 26 89
HYDROCHLOROTHIAZIDE 80 53 28 9
PRAVASTATIN SODIUM 79 45 29 25
LAMOTRIGINE 78 52 30 123
PROAIR HFA 77 49 31 38
RISPERIDONE 76 64 32 95
OXYCODONE HCL-ACETAMINOPHEN 73 38 S2 33 73
CRESTOR 72 63 34 30
SPIRONOLACTONE 70 56 35 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 45 35 111
OXYCODONE HCL 70 0 S2 35 37
PANTOPRAZOLE SODIUM 69 66 38 33
NEXIUM 69 38 38 48
OXYBUTYNIN CHLORIDE 69 59 38 97
ALLOPURINOL 64 55 41 27
MIRTAZAPINE 64 51 41 52
ALENDRONATE SODIUM 63 43 43 14
PROPRANOLOL HCL 62 40 44 127
CLONIDINE HCL 62 37 44 69
CIPROFLOXACIN HCL 62 51 44 58
JANUVIA 62 55 44 59
ESCITALOPRAM OXALATE 61 30 48 98
ATENOLOL 61 55 48 19
IBUPROFEN 58 35 50 60
CYCLOBENZAPRINE HCL 58 28 R 50 75
GLIPIZIDE 58 53 50 36
TAMSULOSIN HCL 57 46 53 24
SYNTHROID 57 47 53 46
ADVAIR DISKUS 56 39 55 47
TRAZODONE HCL 56 41 55 34
CYMBALTA 56 19 55 64
DIGOXIN 53 51 58 92
QUETIAPINE FUMARATE 50 29 59 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.